Mitral annular calcification (MAC) is a progressive, degenerative process increasingly recognised for its clinical impact.

Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), ...

Gold fractals, Bitcoin cost basis heatmap, and long-term moving averages offer clues on where BTC’s next major move may emerge in 2026. Bitcoin is consolidating as gold leads, a pattern seen before ...

Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half of ...

Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...

This article draws heavily on Bill Bengen’s new groundbreaking safe withdrawal rate research and references his latest updates. Bill was kind enough to review the article and his insights are included ...

Michael Ingram is a Senior Contributor from the United States of America. Michael has been writing for GameRant since 2021 with a previous history of personal analytical writing. Michael is a lifelong ...

Please provide your email address to receive an email when new articles are posted on . HF with preserved ejection fraction is common among people with obesity and type 2 diabetes. New real-world data ...

Heart failure with preserved ejection fraction (known as HFpEF), is the most common kind of heart failure, affecting millions globally. The heart still pumps, it just can't relax and fill ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

NEW YORK CITY — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn't benefit the vast majority of patients and may contribute to a higher ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...